Clinical Trial: Ketamine Biomarker Validation

U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07307768) titled 'Ketamine Biomarker Validation' on Dec. 15.

Brief Summary: We will be developing an EEG-based biomarker for the effects of ketamine infusion in patients with Depression. We will be analyzing the effects of ketamine infusion on Depression symptoms and EEG signals.

Study Start Date: Dec. 20

Study Type: INTERVENTIONAL

Condition: Treatment Resistant Depression (TRD)

Intervention: DRUG: Ketamine (0.25 mg/kg)

Low level ketamine infusion therapy.

DRUG: Ketamine (0.5 mg/kg)

Medium level ketamine infusion therapy.

DRUG: Ketamine (0.75 mg/kg)

High level ketamine infusion therapy.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sot...